Nuformix (NFX)

Sector:

Pharma and Biotech

0.095p
   
  • Change Today:
      0.005p
  • 52 Week High: 0.22p
  • 52 Week Low: 0.048p
  • Currency: UK Pounds
  • Shares Issued: 1,669.31m
  • Volume: 15,768,119
  • Market Cap: £1.59m
  • RiskGrade: 322
  • Beta: 0.01

Nuformix Overview

Nuformix is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing. We use our expertise in discovering, developing and patenting novel drug forms with improved physical properties, to develop new products in new indications that are differentiated from the original by way of: dosage, delivery route or presentation, thus creating new and attractive commercial opportunities.
Competitors: Okyo Pharma Limited , Hemogenyx Pharmaceuticals

Key Personnel

Executive Director: Daniel Gooding
Independent Non-Executive Director: Madeleine Kennedy
Non-Executive Chairman: Julian Gilbert
Non-Executive Dir:

Contact Details

Address: 6th Floor, 60 Gracechurch Street, London, United Kingdom, EC3V 0HR
Phone: +44 (0)1223 627222
Website: https://nuformix.com/

Listings

Sector: Pharma and Biotech(LSE)
ISIN: GB00BYW79Y38

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Nuformix Market Data

Currency UK Pounds
Share Price 0.095p
Change Today 0.005p
% Change 5.56 %
52 Week High 0.22p
52 Week Low 0.048p
Volume 15,768,119
Shares Issued 1,669.31m
Market Cap £1.59m
Beta 0.01
RiskGrade 322

Nuformix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.24% below the market average33.24% below the market average33.24% below the market average33.24% below the market average33.24% below the market average
31.91% above the sector average31.91% above the sector average31.91% above the sector average31.91% above the sector average31.91% above the sector average
Price Trend
28.87% below the market average28.87% below the market average28.87% below the market average28.87% below the market average28.87% below the market average
6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average
Income Not Available
Growth Not Available

Nuformix Dividends

No dividends found

Trades for 28-Mar-2025

Time Volume / Share Price
16:01 651,034 @ 0.093p
15:42 450,000 @ 0.099p
15:33 209,366 @ 0.099p
15:07 2,475,858 @ 0.098p
14:25 2,036,144 @ 0.093p

Top of Page